The Non-Malignant Channel is supported with funding from Agios (Gold).
The Sickle Cell Disease Channel is supported with funding from Agios (Gold).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASH 2024 | Preventing and managing vaso-occlusive crises in SCD: the importance of early intervention
Sanne Lugthart, MD, PhD, University Hospitals of Bristol and Weston NHS Foundation Trust, Bristol, UK, comments on the importance of early intervention in preventing and managing vaso-occlusive crises (VOCs) in patients with sickle cell disease (SCD). The implementation of novel predictive models will aid in identifying patients at risk of VOCs and intervening early to avoid progression to severe VOC requiring hospital admission. Dr Lugthart also emphasizes the value of educating patients and healthcare professionals on recognizing and managing VOCs. This interview took place at the 66th ASH Annual Meeting and Exposition, held in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
